Hospira (HSP)
Add to Watchlists Create an Alert
35.09
-0.09 -0.26%
NYSE
May 24, 2:49PM
BATS Real time
Currency in USD
Hospira Revenue Quarterly YoY Growth:
-8.48% for March 31, 2013Hospira Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -8.48% |
| Dec. 31, 2012 | 8.37% |
| Sept. 30, 2012 | 1.77% |
| June 30, 2012 | -2.89% |
| March 31, 2012 | -3.63% |
| Dec. 31, 2011 | 2.21% |
| Sept. 30, 2011 | 2.89% |
| June 30, 2011 | 9.90% |
| March 31, 2011 | -0.53% |
| Dec. 31, 2010 | -5.98% |
| Sept. 30, 2010 | -5.78% |
| June 30, 2010 | 1.18% |
| March 31, 2010 | 17.20% |
| Dec. 31, 2009 | 15.49% |
| Sept. 30, 2009 | 8.86% |
| June 30, 2009 | 6.13% |
| March 31, 2009 | -3.26% |
| Dec. 31, 2008 | -3.43% |
| Sept. 30, 2008 | 10.44% |
| June 30, 2008 | 3.71% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
HSP Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Durect Corporation | -89.92% |
| Cumberland Pharmaceuticals | 0.02% |
| Cubist Pharmaceuticals | 8.61% |
HSP Revenue Quarterly YoY Growth Rankings
| Overall |
51st percentile 3922 of 8009 |
| Sector |
42nd percentile 393 of 687 in Healthcare |
| Industry |
46th percentile 37 of 69 in Drug Manufacturers - Specialty & Generic |
HSP Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -8.48% | Mar 2013 |
| Maximum | 17.20% | Mar 2010 |
| Average | 2.71% |
